{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:15:20Z","timestamp":1780391720838,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"New Zealand Dental Association Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00403-018-1829-5","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T01:22:20Z","timestamp":1523236940000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Expression of IL33 and IL35 in oral lichen planus"],"prefix":"10.1007","volume":"310","author":[{"given":"L. R.","family":"Javvadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P. B.","family":"Parachuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-4245","authenticated-orcid":false,"given":"Alison M.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"1829_CR1","doi-asserted-by":"publisher","first-page":"e1-12","DOI":"10.1016\/j.tripleo.2006.11.001","volume":"103","author":"I Al-Hashimi","year":"2007","unstructured":"Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA et al (2007) Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:e1-12","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1829_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tripleo.2004.06.077","volume":"100","author":"G Lodi","year":"2005","unstructured":"Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 100:40\u201351","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endo"},{"key":"1829_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/154411130201300405","volume":"13","author":"PB Sugerman","year":"2002","unstructured":"Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A et al (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13:350\u2013365","journal-title":"Crit Rev Oral Biol Med"},{"key":"1829_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479\u2013490","journal-title":"Immunity"},{"key":"1829_CR5","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","volume":"179","author":"Z Allakhverdi","year":"2007","unstructured":"Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051\u20132054","journal-title":"J Immunol"},{"key":"1829_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/exd.12008","volume":"21","author":"A Balato","year":"2012","unstructured":"Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A et al (2012) IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 21:876\u2013894","journal-title":"Exp Dermatol"},{"key":"1829_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/art.24305","volume":"60","author":"G Palmer","year":"2009","unstructured":"Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S et al (2009) Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheumatol 60:738\u2013749","journal-title":"Arthritis Rheumatol"},{"key":"1829_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-016-0559-z","volume":"38","author":"LA Borthwick","year":"2016","unstructured":"Borthwick LA (2016) The IL-2 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol 2016 38:517\u2013534","journal-title":"Semin Immunopathol"},{"key":"1829_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","volume":"31","author":"AU Luthi","year":"2009","unstructured":"Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84\u201398","journal-title":"Immunity"},{"issue":"8","key":"1829_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","volume":"20","author":"MD Smithgall","year":"2008","unstructured":"Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20(8):1019\u20131030","journal-title":"Int Immunol"},{"key":"1829_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L et al (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Nat Acad Sci USA 104:282\u2013287","journal-title":"Proc Nat Acad Sci USA"},{"key":"1829_CR12","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/jid.2012.185","volume":"132","author":"J Meephansan","year":"2012","unstructured":"Meephansan J, Tsuda H, Komine M, Tominaga S, Ohtsuki M (2012) Regulation of IL-33 expression by IFN-gamma and tumor necrosis factor-alpha in normal human epidermal keratinocytes. J Investig Dermatol 132:2593\u20132600","journal-title":"J Investig Dermatol"},{"key":"1829_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566\u2013569","journal-title":"Nature"},{"key":"1829_CR14","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","volume":"94","author":"O Devergne","year":"1997","unstructured":"Devergne O, Birkenbach M, Kieff E (1997) Epstein\u2013Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Nat Acad Sci USA 94:12041\u201312046","journal-title":"Proc Nat Acad Sci USA"},{"key":"1829_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2227","volume":"13","author":"LW Collison","year":"2012","unstructured":"Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D et al (2012) The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 13:290\u2013299","journal-title":"Nat Immunol"},{"key":"1829_CR16","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/1078-0432.CCR-16-0743","volume":"22","author":"Y Pylayeva-Gupta","year":"2016","unstructured":"Pylayeva-Gupta Y (2016) Molecular pathways: interleukin-35 in autoimmunity and cancer. Clin Cancer Res 22:4973\u20134978","journal-title":"Clin Cancer Res"},{"key":"1829_CR17","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.4049\/jimmunol.1100315","volume":"186","author":"V Chaturvedi","year":"2011","unstructured":"Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA (2011) Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 186:6661\u20136666","journal-title":"J Immunol"},{"key":"1829_CR18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/eji.201445217","volume":"45","author":"KO Dixon","year":"2015","unstructured":"Dixon KO, van der Kooij SW, Vignali DA, van Kooten C (2015) Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members. Eur J Immunol 45:1736\u20131747","journal-title":"Eur J Immunol"},{"key":"1829_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O\u2019Connor RA, Stervbo U, Hilgenberg E et al (2014) IL-35 producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507:366\u2013370","journal-title":"Nature"},{"key":"1829_CR20","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","volume":"37","author":"W Niedbala","year":"2007","unstructured":"Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB et al (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37:3021\u20133029","journal-title":"Eur J Immunol"},{"key":"1829_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J et al (2010) IL-35 mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093\u20131101","journal-title":"Nat Immunol"},{"key":"1829_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1034\/j.1600-0714.2003.00125.x","volume":"32","author":"EH Meij van der","year":"2003","unstructured":"van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32:507\u2013512","journal-title":"J Oral Pathol Med"},{"key":"1829_CR23","first-page":"E310-3144","volume":"14","author":"I Waal van der","year":"2009","unstructured":"van der Waal I (2009) Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal 14:E310-3144","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1829_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4248\/IJOS10028","volume":"2","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Jiang L, Liu J, Zeng X, Chen QM (2010) The prevalence of hepatitis C virus infection in oral lichen planus in an ethnic Chinese cohort of 232 patients. Int J Oral Sci 2:90\u201397","journal-title":"Int J Oral Sci"},{"key":"1829_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pathol.2016.06.002","volume":"48","author":"LR Javvadi","year":"2016","unstructured":"Javvadi LR, Parachuru VPB, Milne TJ, Seymour GJ, Rich AM (2016) Regulatory T-cells and IL17A+cells infiltrate oral lichen planus lesions. Pathol 48:564\u2013573","journal-title":"Pathol"},{"key":"1829_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2567.2009.03221.x","volume":"130","author":"CJ Nile","year":"2010","unstructured":"Nile CJ, Barksby E, Jitprasertwong P, Preshaw PM, Taylor JJ (2010) Expression and regulation of interleukin-33 in human monocytes. Immunol 130:172\u2013180","journal-title":"Immunol"},{"key":"1829_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2010.02.110","volume":"394","author":"T Shimosato","year":"2010","unstructured":"Shimosato T, Fujimoto M, Tohno M, Sato T, Tateo M, Otani H et al (2010) CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9. Biochem Biophys Res Commun 394:81\u201386","journal-title":"Biochem Biophys Res Commun"},{"key":"1829_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1034\/j.1600-0714.2003.00077.x","volume":"32","author":"A Khan","year":"2003","unstructured":"Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB (2003) Th1 cytokines in oral lichen planus. J Oral Pathol Med 32:77\u201383","journal-title":"J Oral Pathol Med"},{"key":"1829_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1600-0714.1998.tb01917.x","volume":"27","author":"C Simark Mattsson","year":"1998","unstructured":"Simark Mattsson C, Jontell M, Bergenholtz G, Heyden M, Dahlgren UI (1998) Distribution of interferon-gamma mRNA-positive cells in oral lichen planus lesions. J Oral Pathol Med 27:483\u2013488","journal-title":"J Oral Pathol Med"},{"key":"1829_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0003-9969(99)00013-8","volume":"44","author":"C Simark-Mattsson","year":"1999","unstructured":"Simark-Mattsson C, Bergenholtz G, Jontell M, Eklund C, Seymour GJ, Sugerman PB et al (1999) Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 44:499\u2013507","journal-title":"Arch Oral Biol"},{"key":"1829_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","volume":"163","author":"ES Baekkevold","year":"2003","unstructured":"Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F et al (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163:69\u201379","journal-title":"Am J Pathol"},{"key":"1829_CR32","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.4049\/jimmunol.1003080","volume":"187","author":"S Ali","year":"2011","unstructured":"Ali S, Mohs A, Thomas M, Klare J, Ross R, Schmitz ML et al (2011) The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 187:1609\u20131616","journal-title":"J Immunol"},{"key":"1829_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00403-015-1540-8","volume":"307","author":"FA Firth","year":"2015","unstructured":"Firth FA, Friedlander LT, Parachuru VPB, Kardos TB, Seymour GJ, Rich AM (2015) Regulation of immune cells in oral lichen planus. Arch Dermatol Res 307:333\u2013339","journal-title":"Arch Dermatol Res"},{"key":"1829_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1601-0825.2009.01608.x","volume":"16","author":"XA Tao","year":"2010","unstructured":"Tao XA, Xia J, Chen XB, Wang H, Dai YH, Rhodus NL et al (2010) FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis 16:76\u201382","journal-title":"Oral Dis"},{"key":"1829_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/eji.201646493","volume":"47","author":"F Manzoor","year":"2017","unstructured":"Manzoor F, Johnson MC, Li C, Samulski RJ, Wang B, Tisch R (2017) \u03b2-cell-specific IL-35 therapy suppresses ongoing antoimmune diabetes in NOD mice. Eur J Immunol 47:144\u2013154","journal-title":"Eur J Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-018-1829-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T01:43:21Z","timestamp":1554774201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-018-1829-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1007\/s00403-018-1829-5","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"26 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No authors have any conflicts of interest with regard to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The project received ethical approval from the University of Otago Human Ethics Committee (Reference number H13\/052) and all patients whose tissue was used had consented to the use their residual tissue, after diagnostic investigations had been completed, for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}